{"FP": [{"generated": ["medicinal cannabis"], "gold": [], "text": "This case report highlights the complexity associated with medicinal cannabis and the health risks associated with its use."}, {"generated": ["cannabis"], "gold": [], "text": "It was discovered that the patient took cannabis for chronic back pain, and a pharmacogenomics (PGx) test indicated the presence of variants for the COMT and HTR2A genes."}, {"generated": ["none"], "gold": [], "text": "Additionally, a previous study evaluated patients with PD and their subsequent reactions to cannabis use, reporting that one out of five patients experienced hallucinations [12]."}, {"generated": ["parts of herb"], "gold": [], "text": "An important fact is that most of these affected drugs have very narrow therapeutic indices."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "To date an increasing number of studies in evaluating HDIs have been reported [11]."}, {"generated": ["important herb products"], "gold": [], "text": "In the following, we reviewed pharmacogenomics studies, mainly from clinic study, on some important herb products that have been reported to have HDIs."}, {"generated": ["traditional hypoglycemic herbs"], "gold": [], "text": "Therefore, rs1142345 was associated with the clinical effect of traditional hypoglycemic herbs."}, {"generated": ["Not applicable"], "gold": [], "text": "AUC: concentration-time curve; EMs: extensive metabolizer; PM: poor metabolizer."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "With the boom in conventional therapeutic drugs, the utilization of herbal remedies sometimes in combination with other medications has increased tremendously over the last decade [1,2]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Linear regression analysis of the time course was used to determine the K A non-targeted approach was used in order to provide information about all possible metabolites present in the analysed samples."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "With the tremendous surge in the acceptance of and public interest in herbal medicinal remedies, researchers are adopting the guidelines and opinions proposed for DDI studies to study HDI."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "The TDI effects of these herbals is felt when patients chronically use them because sufficient intermediary metabolites may be generated and this can be deleterious to consumers concomitantly taking conventional medications, as stated earlier."}, {"generated": ["None"], "gold": [], "text": "Extraction was performed using water to mimic the indigenous mode of extraction."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "[44]."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "[44]."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "[44]."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "[44]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Briefly, serial dilutions of the extracts were added to a mixture of regeneration system, NADP Phytofingerprinting was performed on the extracts using a Waters Acquity UPLC system (Waters Corporation, Milford, MA, USA) with an Acquity BEH C18 column (2.1 mm \u00d7 100 mm, 1.7 \u00b5m particle size) incorporating a binary pump, vacuum degasser, autosampler, column oven, and Micromass Xevo tandem quadrupole mass spectrometric detector (QTOF xevo G2; Waters micromass, Manchester, UK) equipped with ESI probe."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Currently, there is no specific pharmacological tool to predict HDI since almost all in vitro-in vivo-extrapolation (IVIVE) Drug-Drug Interaction (DDI) models deal with one inhibitor-drug and one victim-drug."}, {"generated": ["Oat3", "Oat1"], "gold": [], "text": "Further, unique substrates that interact with Oat1, but not with Oat3 (and vice-versa) have been identified [7]."}, {"generated": ["Oat3", "Oat1"], "gold": [], "text": "Further, unique substrates that interact with Oat1, but not with Oat3 (and vice-versa) have been identified [7]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "For the most part these latter two transporter families and the OATs have fairly distinct substrate interactions; however, the possibility that they also may contribute to the overall clinical pharmacokinetic profile of Danshen components in vivo needs to be considered until investigated directly."}, {"generated": ["St John's wort"], "gold": [], "text": "Keywords: pharmacokinetics, pharmacodynamics, gliclazide, St John's wort, CYP2C9, genotype Go to: Introduction  The incidence of type 2 diabetes is increasing in the community."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Furthermore, 31% of diabetic patients have been reported to take alternative medicines, most in conjunction with conventional medicines (Ryan et al., 2001)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Four of these metabolites (6\u03b1, 6\u03b2, 7\u03b1 and 7\u03b2 positions) have been identified in urine, which represented 1, 20, 6 and 14% of urinary recovered dose 96\u2009h after dose, respectively (Oida et al., 1985)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Elliot et al."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "(2003)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Park et al."}, {"generated": ["black cohosh"], "gold": [], "text": "The American College of Obstetrics and Gynecology included black cohosh as a possible remedy for the vasomotor symptoms of menopause [15]."}, {"generated": ["unspecified herbal supplement"], "gold": [], "text": "This case culminated in liver failure despite discontinuation of the herbal supplement [4]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "The immune mechanism is precipitated by a drug or a metabolite acting as a hapten covalently binding to host cellular protein, converting into an immunogen [24] and thereby eliciting an autoimmune response."}, {"generated": ["black cohosh"], "gold": [], "text": "Similarities and differences among current case studies and published cases of black cohosh hepatotoxicity."}, {"generated": ["Polygonum capitatum"], "gold": [], "text": "For patients with urinary system infection, Relinqing\u00ae granule from Polygonum capitatum is usually combined with LVFX."}, {"generated": ["puerarin"], "gold": [], "text": "Thereafter, 50\u2009\u03bcL of the IS solution (puerarin, 20\u2009ng/mL in methanol) and 50\u2009\u03bcL of 2% formic acid were added to 100\u2009\u03bcL of the rat tissue homogenate."}, {"generated": ["Group one"], "gold": [], "text": "Group one was administered 42\u2009mg\u00b7kg Data are presented as mean\u2009\u00b1\u2009standard deviation (SD)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "At present, our current studies at the pharmacokinetic level may not be able to explain this problem strongly."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "KY[2017]073)."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "KY[2017]073)."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "KY[2017]073)."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "KY[2017]073)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "People with diabetes receiving this combination should be closely monitored to evaluate possible signs of reduced efficacy."}, {"generated": ["No information found"], "gold": [], "text": "Radio labeled digoxin [ Parental and transfected MDCK-II cells were grown in DMEM supplemented with 10% FBS, 1% non-essential amino acids, 1%  The assay for reversible inhibition was conducted in a total volume of 200 \u03bcL in 96-well microplates."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "*P < 0.05, **P < 0.01, and ***P < 0.001, determined by One way ANOVA, followed by Dunnett\u2019s multiple comparison tests."}, {"generated": ["Flavonoids"], "gold": [], "text": "Flavonoids, common in the diet, are responsible for the modulation of the clinically relevant CYP2C8, CYP2C9, and CYP3A4 enzymes [31]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Qualitative screening of extracts and compounds was used to identify potential inhibitory effects on CYP2C8, CYP2C9 and CYP3A4."}, {"generated": ["sulfaphenazole", "quercetin", "ketoconazole"], "gold": [], "text": "quercetin (positive CYP2C8 inhibitor), sulfaphenazole (positive CYP2C9 inhibitor), and ketoconazole (positive CYP3A4 inhibitor)."}, {"generated": ["sulfaphenazole", "quercetin", "ketoconazole"], "gold": [], "text": "quercetin (positive CYP2C8 inhibitor), sulfaphenazole (positive CYP2C9 inhibitor), and ketoconazole (positive CYP3A4 inhibitor)."}, {"generated": ["sulfaphenazole", "quercetin", "ketoconazole"], "gold": [], "text": "quercetin (positive CYP2C8 inhibitor), sulfaphenazole (positive CYP2C9 inhibitor), and ketoconazole (positive CYP3A4 inhibitor)."}, {"generated": ["Echinacea"], "gold": [], "text": "Echinacea was well tolerated, and all participants completed the study."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "2)."}, {"generated": ["ethanolic liquid extracts"], "gold": [], "text": "Of these components, caffeic acid derivatives and the more bioavailable alkylamides are found in ethanolic liquid extracts for medicinal use [8]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "For example, the potent P-gp inhibitors R101933 [27, 28] and zosuquidar [29] did not significantly alter plasma levels of docetaxel in cancer patients."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Thus, the risk of CYP3A4-mediated interactions may be product dependent."}, {"generated": ["EGCG", "EGC", "GTECG", "GTC"], "gold": [], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["EGCG", "EGC", "GTECG", "GTC"], "gold": [], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["EGCG", "EGC", "GTECG", "GTC"], "gold": [], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["EGCG", "EGC", "GTECG", "GTC"], "gold": [], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["catechin"], "gold": [], "text": "Relationship between the catechin AUC Abbreviations: AUC Subject baseline characteristics at the start of the study Note: Data are presented as mean \u00b1 SD for continuous variables and as ratios for categorical variables."}, {"generated": ["Red ginseng"], "gold": [], "text": "Sample Availability: Red ginseng extract are available from the authors."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Conceptualization, M.-K.C."}, {"generated": ["Rizeki"], "gold": [], "text": "Contents of ginsenosides in RGE."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "2016; Bautista et\u00a0al."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "2014; Dybro et\u00a0al."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "However, it is unknown whether there is an interaction between AC and DST."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "; 3.5\u2009\u03bcm) at room temperature."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "The half-life (t Experimental values are expressed as mean\u2009\u00b1\u2009SD."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "The results of existing studies are controversial and further in-depth studies are required."}, {"generated": ["parts of herb"], "gold": [], "text": "Most of these reports and studies are on combinations with Western drugs."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Based on our analysis of the literature, the mechanism of interaction between TCM formulations and digoxin is as follows: A."}, {"generated": ["Chuanxiong", "Ginkgo biloba", "Carica papaya", "Tapinanthus sessilifolius", "Biantaobanjiuju"], "gold": [], "text": "In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing)."}, {"generated": ["Chuanxiong", "Ginkgo biloba", "Carica papaya", "Tapinanthus sessilifolius", "Biantaobanjiuju"], "gold": [], "text": "In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing)."}, {"generated": ["Chuanxiong", "Ginkgo biloba", "Carica papaya", "Tapinanthus sessilifolius", "Biantaobanjiuju"], "gold": [], "text": "In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing)."}, {"generated": ["Chuanxiong", "Ginkgo biloba", "Carica papaya", "Tapinanthus sessilifolius", "Biantaobanjiuju"], "gold": [], "text": "In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing)."}, {"generated": ["Chuanxiong", "Ginkgo biloba", "Carica papaya", "Tapinanthus sessilifolius", "Biantaobanjiuju"], "gold": [], "text": "In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Li Xin et al."}, {"generated": ["None"], "gold": [], "text": "When the bias of medicine is greater than that of food, it will inevitably affect the balance of qi, blood, yin and yang of the human body (Jia et al., 2021)."}, {"generated": ["Not applicable"], "gold": [], "text": "Although a lot of experience has been accumulated in the clinical application of digoxin over the years, limited research has been conducted on its possible interactions with TCM formulations."}, {"generated": ["parts of herb"], "gold": [], "text": "The composition of TCM formulations is complex."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Many view these medicines as benign because they are of natural origin; however, because their constituents may be metabolized through the same enzymatic pathways as pharmaceutical agents, there is a potential for herb-drug interactions."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "None of the aforementioned studies investigated the effects on drug-metabolizing enzymes of the type of extract (CAW) used in our preclinical studies and in our current phase I (NCT03929250, NCT03937908) and proposed phase II clinical trials investigating CAW as a botanical drug for cognitive decline."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Unless otherwise specified, all results were expressed as the means \u00b1 S.D."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "To determine the IC50 values, the concentration-response (percentage control value) curves were fitted to a four-parameter sigmoid (Hill) model, according to eq."}, {"generated": ["parts of herb"], "gold": [], "text": "2 above (substituting logEC50 for logIC50)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Object name is dmd.120.090860f1.jpg Fig."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Mean\tS.D."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Mean\tS.D."}, {"generated": ["parts of herb"], "gold": [], "text": "***P < 0.0001."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "; data not shown)."}, {"generated": ["parts of herb used found in text"], "gold": [], "text": "3; Table 8) in a manner consistent with the literature (Ring et al., 1996; Suzuki et al., 2002; Emoto et al., 2003; Walsky et al., 2006; VandenBrink et al., 2011; Zhao et al., 2012; Thu et al., 2017)."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Object name is dmd.120.090860f3.jpg Fig."}, {"generated": ["parts of herb"], "gold": [], "text": "Data shown are the means \u00b1 S.D."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "of triplicate determinations."}, {"generated": ["Purified centelloids"], "gold": [], "text": "Purified centelloids are weak inhibitors in human liver microsomes and human P450 forms expressed by E. coli of CYP2C19, CYP3A4, CYP2D6, and CYP2C9."}, {"generated": ["CAW-R61J"], "gold": [], "text": "Based on the centelloid content of CAW-R61J, we expect similar plasma concentrations for these compounds in our clinical studies using this extract."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Three concentrations of quality control (QC) samples were prepared at low, medium, and high concentrations in the range of the standard calibration curves."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "We also used the same MRM condition as previously published reports [39,40] and the product ion mass spectra from fimasartan, amlodipine, and hydrochlorothiazide showed different mass fragmentation patterns (Figure 1)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "and M.P."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Data represented as mean and CV from five or six independent experiments."}, {"generated": ["NVP", "EFV"], "gold": [], "text": "EFV and NVP have been associated with a number of side effects including liver damage, nausea, vomiting, fever, diarrhoea, dyslipidemia and headache [10]."}, {"generated": ["NVP", "EFV"], "gold": [], "text": "EFV and NVP have been associated with a number of side effects including liver damage, nausea, vomiting, fever, diarrhoea, dyslipidemia and headache [10]."}, {"generated": ["medicinal plants"], "gold": [], "text": "There is substantial evidence supporting the potential of medicinal plants in combating diseases, especially in developing countries [12,13,14,15]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Although effective in the treatment of some diseases, the mechanisms of action for most herbal medicines remain largely unknown."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "The advantage of phytochemical profiling is that similar drug interacting constituents could be identified in other related herbs that are used for therapeutic purposes and that necessary mechanistic studies are performed on them."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Denis Chopera, Kevin Dzobo, Ambroise Wonkam, Dee Blackhurst and Michelle Skelton commented."}, {"generated": ["five major ingredients"], "gold": [], "text": "GGT with five major ingredients also possesses chance of drug interactions when co-administering with other drugs."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "and Y.C.P."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "; performing modeling, Q.T.T., H.-m.B., L.T.N., J.-w.C., and H.-y.Y."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "[1\u20133,8,9] Still other surveys indicate that herbal supplement usage is prevalent among patients taking prescription medications,[10\u201312] with many individuals greater than 65 years of age."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Table I  Pre- and Postsupplementation Phenotypic Ratios (means, 95% confidence intervals) Phenotypic Ratio (CYP)\tSupplement\tPresupplementation (mean and 95% CI)\tPostsupplementation."}, {"generated": ["not specified in the provided text"], "gold": [], "text": "This finding also corroborates the results of an earlier study in young individuals."}, {"generated": ["St. John\u2019s wort"], "gold": [], "text": "[54] Thus, a potential interaction may exist between these agents and St. John\u2019s wort."}, {"generated": ["allyl sulfide"], "gold": [], "text": "[42] The difference in extent of inhibition between the two age groups hints at either an age-related diminution in CYP2E1 responsivity or a dissimilarity in allyl sulfide content between the garlic supplements."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "[11,12] Such an interaction is particularly relevant to elderly patients on anticoagulant therapy."}, {"generated": ["ginseng"], "gold": [], "text": "[62] CYP2C9 is the principal isoform involved in the biotransformation of warfarin (more particularly the active enantiomer, S-warfarin) and the aforementioned reports hint strongly at a ginseng-mediated induction of this enzyme."}, {"generated": ["Botanical supplements"], "gold": [], "text": "Therefore, botanical supplements, when taken concomitantly with conventional medications, can give rise to serious herb-drug interactions."}, {"generated": ["3-hydroxyquinine"], "gold": [], "text": "The limit of quantitation was 0.37\u00b5g/ml and 0.5\u00b5g/ml for quinine and for 3-hydroxyquinine respectively."}, {"generated": ["quinine"], "gold": [], "text": "The AUC0\u2013\u221e of quinine was slightly reduced by about 9 %."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Abbreviations: HDL (high density lipoprotein); LDL (low density lipoprotein) *P-value for interaction effect of groups over time."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "(PDF) Click here for additional data file."}, {"generated": ["Thatch"], "gold": [], "text": "Thabethe, D.A."}, {"generated": ["List of parts of herb used"], "gold": [], "text": "Data were reported as prevalence (percent) of the occurrence."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "However, a large number of these therapies have been shown that they are not safe and can be harmful due to their interactions with other drugs which are used contemporaneously."}, {"generated": ["no specific herb parts mentioned in the provided text"], "gold": [], "text": "[27] In the study performed by Roozbeh et al."}, {"generated": ["herbal formulas"], "gold": [], "text": "Therefore, we think that a comprehensive management of our patients should also include education about the risk of interactions with herbal formulas."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Percentage factor activity for each sample was obtained from a standard curve constructed using different dilutions of standard human plasma of known factor activity and clotting time."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "The half-life was calculated as ln\u20092/kel, the apparent clearance (CL/F) as dose/AUC0\u2212\u221e and the apparent volume of distribution (V/F) as CL/kel."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "In brief, a two-compartment pharmacokinetic model was used to describe S-warfarin concentration\u2013time data and an indirect pharmacodynamic model described the relationship between percentage of prothrombin complex activity (PCA; which was derived from the INR data in this study) and S-warfarin concentration."}, {"generated": ["cranberry", "garlic", "S-warfarin", "R-warfarin"], "gold": [], "text": "Table 2  Pharmacokinetic parameters of S-warfarin and R-warfarin  \tMean (95% CI)\tGeometric mean ratio (90% CI)  \tWarfarin only\tWarfarin and cranberry\tWarfarin and garlic\tWarfarin and cranberry/warfarin only\tWarfarin and garlic/warfarin only S-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.3 (1.1\u20131.6)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20131.9)\t1.7 (1.5\u20132.0)\t1.9 (1.5\u20132.2)\t0.94 (0.67\u20131.29)\t1.06 (0.77\u20131.47) \u2003t1/2 (h)\t38.6 (35.7\u201341.5)\t34.9 (31.0\u201338.8)\t41.2 (35.1\u201347.3)\t0.94 (0.79\u20131.12)\t0.99 (0.83\u20131.18) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t60.3 (54.5\u201366.1)\t63.0 (57.3\u201368.8)\t65.5 (55.3\u201375.6)\t1.04 (0.94\u20131.67)\t1.06 (0.95\u20131.19) \u2003CL/F (mL\u2009h\u22121)\t213 (193\u2013232)\t204 (183\u2013224)\t202 (175\u2013229)\t0.89 (0.80\u20130.99)\t1.05 (0.94\u20131.17) \u2003Fraction unbound (fu)\t0.010 (0.007\u20130.013)\t0.010 (0.007\u20130.014)\t0.011 (0.008\u20130.014)\t1.00 (0.75\u20131.25)\t1.12 (0.39\u20131.84)  \t \t \t \t \t  R-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.8 (0.7\u20132.9)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20132.0)\t1.7 (1.5\u20131.9)\t1.9 (1.5\u20132.2)\t0.90 (0.67\u20131.21)\t1.02 (0.8\u20131.4) \u2003t1/2 (h)\t55.6 (46.2\u201365.0)\t47.7 (41.5\u201353.9)\t52.6 (47.4\u201357.9)\t0.93 (0.80\u20131.08)\t0.98 (0.84\u20131.14) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t108.7 (90.0\u2013127.3)\t105.8 (91.7\u2013119.9)\t105.0 (96.3\u2013113.7)\t1.0 (0.9\u20131.1)\t0.99 (0.87\u20131.13) \u2003CL/F (mL\u2009h\u22121)\t123 (106\u2013140)\t124 (109\u2013139)\t121 (112\u2013131)\t0.87 (0.75\u20130.99)\t0.96 (0.84\u20131.11) \u2003Fraction unbound (fu)\t0.006 (0.004\u20130.007)\t0.005 (0.004\u20130.007)\t0.006 (0.004\u20130.007)\t0.95 (0.72\u20131.18)\t1.04 (0.80\u20131.29) Open in a separate window Abbreviations: AUC, area under the plasma concentration\u2013time curve; CI, confidence interval; CL, clearance; CL/F, apparent clearance; Cmax, maximum concentration; F, bioavailability; NA, not applicable; tmax, time to Cmax."}, {"generated": ["cranberry", "garlic", "S-warfarin", "R-warfarin"], "gold": [], "text": "Table 2  Pharmacokinetic parameters of S-warfarin and R-warfarin  \tMean (95% CI)\tGeometric mean ratio (90% CI)  \tWarfarin only\tWarfarin and cranberry\tWarfarin and garlic\tWarfarin and cranberry/warfarin only\tWarfarin and garlic/warfarin only S-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.3 (1.1\u20131.6)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20131.9)\t1.7 (1.5\u20132.0)\t1.9 (1.5\u20132.2)\t0.94 (0.67\u20131.29)\t1.06 (0.77\u20131.47) \u2003t1/2 (h)\t38.6 (35.7\u201341.5)\t34.9 (31.0\u201338.8)\t41.2 (35.1\u201347.3)\t0.94 (0.79\u20131.12)\t0.99 (0.83\u20131.18) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t60.3 (54.5\u201366.1)\t63.0 (57.3\u201368.8)\t65.5 (55.3\u201375.6)\t1.04 (0.94\u20131.67)\t1.06 (0.95\u20131.19) \u2003CL/F (mL\u2009h\u22121)\t213 (193\u2013232)\t204 (183\u2013224)\t202 (175\u2013229)\t0.89 (0.80\u20130.99)\t1.05 (0.94\u20131.17) \u2003Fraction unbound (fu)\t0.010 (0.007\u20130.013)\t0.010 (0.007\u20130.014)\t0.011 (0.008\u20130.014)\t1.00 (0.75\u20131.25)\t1.12 (0.39\u20131.84)  \t \t \t \t \t  R-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.8 (0.7\u20132.9)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20132.0)\t1.7 (1.5\u20131.9)\t1.9 (1.5\u20132.2)\t0.90 (0.67\u20131.21)\t1.02 (0.8\u20131.4) \u2003t1/2 (h)\t55.6 (46.2\u201365.0)\t47.7 (41.5\u201353.9)\t52.6 (47.4\u201357.9)\t0.93 (0.80\u20131.08)\t0.98 (0.84\u20131.14) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t108.7 (90.0\u2013127.3)\t105.8 (91.7\u2013119.9)\t105.0 (96.3\u2013113.7)\t1.0 (0.9\u20131.1)\t0.99 (0.87\u20131.13) \u2003CL/F (mL\u2009h\u22121)\t123 (106\u2013140)\t124 (109\u2013139)\t121 (112\u2013131)\t0.87 (0.75\u20130.99)\t0.96 (0.84\u20131.11) \u2003Fraction unbound (fu)\t0.006 (0.004\u20130.007)\t0.005 (0.004\u20130.007)\t0.006 (0.004\u20130.007)\t0.95 (0.72\u20131.18)\t1.04 (0.80\u20131.29) Open in a separate window Abbreviations: AUC, area under the plasma concentration\u2013time curve; CI, confidence interval; CL, clearance; CL/F, apparent clearance; Cmax, maximum concentration; F, bioavailability; NA, not applicable; tmax, time to Cmax."}, {"generated": ["cranberry", "garlic", "S-warfarin", "R-warfarin"], "gold": [], "text": "Table 2  Pharmacokinetic parameters of S-warfarin and R-warfarin  \tMean (95% CI)\tGeometric mean ratio (90% CI)  \tWarfarin only\tWarfarin and cranberry\tWarfarin and garlic\tWarfarin and cranberry/warfarin only\tWarfarin and garlic/warfarin only S-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.3 (1.1\u20131.6)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20131.9)\t1.7 (1.5\u20132.0)\t1.9 (1.5\u20132.2)\t0.94 (0.67\u20131.29)\t1.06 (0.77\u20131.47) \u2003t1/2 (h)\t38.6 (35.7\u201341.5)\t34.9 (31.0\u201338.8)\t41.2 (35.1\u201347.3)\t0.94 (0.79\u20131.12)\t0.99 (0.83\u20131.18) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t60.3 (54.5\u201366.1)\t63.0 (57.3\u201368.8)\t65.5 (55.3\u201375.6)\t1.04 (0.94\u20131.67)\t1.06 (0.95\u20131.19) \u2003CL/F (mL\u2009h\u22121)\t213 (193\u2013232)\t204 (183\u2013224)\t202 (175\u2013229)\t0.89 (0.80\u20130.99)\t1.05 (0.94\u20131.17) \u2003Fraction unbound (fu)\t0.010 (0.007\u20130.013)\t0.010 (0.007\u20130.014)\t0.011 (0.008\u20130.014)\t1.00 (0.75\u20131.25)\t1.12 (0.39\u20131.84)  \t \t \t \t \t  R-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.8 (0.7\u20132.9)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20132.0)\t1.7 (1.5\u20131.9)\t1.9 (1.5\u20132.2)\t0.90 (0.67\u20131.21)\t1.02 (0.8\u20131.4) \u2003t1/2 (h)\t55.6 (46.2\u201365.0)\t47.7 (41.5\u201353.9)\t52.6 (47.4\u201357.9)\t0.93 (0.80\u20131.08)\t0.98 (0.84\u20131.14) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t108.7 (90.0\u2013127.3)\t105.8 (91.7\u2013119.9)\t105.0 (96.3\u2013113.7)\t1.0 (0.9\u20131.1)\t0.99 (0.87\u20131.13) \u2003CL/F (mL\u2009h\u22121)\t123 (106\u2013140)\t124 (109\u2013139)\t121 (112\u2013131)\t0.87 (0.75\u20130.99)\t0.96 (0.84\u20131.11) \u2003Fraction unbound (fu)\t0.006 (0.004\u20130.007)\t0.005 (0.004\u20130.007)\t0.006 (0.004\u20130.007)\t0.95 (0.72\u20131.18)\t1.04 (0.80\u20131.29) Open in a separate window Abbreviations: AUC, area under the plasma concentration\u2013time curve; CI, confidence interval; CL, clearance; CL/F, apparent clearance; Cmax, maximum concentration; F, bioavailability; NA, not applicable; tmax, time to Cmax."}, {"generated": ["cranberry", "garlic", "S-warfarin", "R-warfarin"], "gold": [], "text": "Table 2  Pharmacokinetic parameters of S-warfarin and R-warfarin  \tMean (95% CI)\tGeometric mean ratio (90% CI)  \tWarfarin only\tWarfarin and cranberry\tWarfarin and garlic\tWarfarin and cranberry/warfarin only\tWarfarin and garlic/warfarin only S-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.3 (1.1\u20131.6)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20131.9)\t1.7 (1.5\u20132.0)\t1.9 (1.5\u20132.2)\t0.94 (0.67\u20131.29)\t1.06 (0.77\u20131.47) \u2003t1/2 (h)\t38.6 (35.7\u201341.5)\t34.9 (31.0\u201338.8)\t41.2 (35.1\u201347.3)\t0.94 (0.79\u20131.12)\t0.99 (0.83\u20131.18) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t60.3 (54.5\u201366.1)\t63.0 (57.3\u201368.8)\t65.5 (55.3\u201375.6)\t1.04 (0.94\u20131.67)\t1.06 (0.95\u20131.19) \u2003CL/F (mL\u2009h\u22121)\t213 (193\u2013232)\t204 (183\u2013224)\t202 (175\u2013229)\t0.89 (0.80\u20130.99)\t1.05 (0.94\u20131.17) \u2003Fraction unbound (fu)\t0.010 (0.007\u20130.013)\t0.010 (0.007\u20130.014)\t0.011 (0.008\u20130.014)\t1.00 (0.75\u20131.25)\t1.12 (0.39\u20131.84)  \t \t \t \t \t  R-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.8 (0.7\u20132.9)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20132.0)\t1.7 (1.5\u20131.9)\t1.9 (1.5\u20132.2)\t0.90 (0.67\u20131.21)\t1.02 (0.8\u20131.4) \u2003t1/2 (h)\t55.6 (46.2\u201365.0)\t47.7 (41.5\u201353.9)\t52.6 (47.4\u201357.9)\t0.93 (0.80\u20131.08)\t0.98 (0.84\u20131.14) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t108.7 (90.0\u2013127.3)\t105.8 (91.7\u2013119.9)\t105.0 (96.3\u2013113.7)\t1.0 (0.9\u20131.1)\t0.99 (0.87\u20131.13) \u2003CL/F (mL\u2009h\u22121)\t123 (106\u2013140)\t124 (109\u2013139)\t121 (112\u2013131)\t0.87 (0.75\u20130.99)\t0.96 (0.84\u20131.11) \u2003Fraction unbound (fu)\t0.006 (0.004\u20130.007)\t0.005 (0.004\u20130.007)\t0.006 (0.004\u20130.007)\t0.95 (0.72\u20131.18)\t1.04 (0.80\u20131.29) Open in a separate window Abbreviations: AUC, area under the plasma concentration\u2013time curve; CI, confidence interval; CL, clearance; CL/F, apparent clearance; Cmax, maximum concentration; F, bioavailability; NA, not applicable; tmax, time to Cmax."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Pharmacokinetic\u2013pharmacodynamic modelling  The population PKPD parameter estimates for warfarin are presented in the Table 3."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "(2006b) included 7 patients with atrial fibrillation, whereas Ansell et al."}, {"generated": ["valerian"], "gold": [], "text": "Academic Editor: Igho J. Onakpoya In recent popular publications as well as in widely used information websites directed to cancer patients, valerian is claimed to have a potential of adverse interactions with anticancer drugs."}, {"generated": ["Valerian"], "gold": [], "text": "However, they state that warnings that valerian (Valeriana officinalis) may stimulate CYP 3A4."}, {"generated": ["valerian root"], "gold": ["root"], "text": "Recommended daily doses of valerian root extracts are about 600\u2009mg, usually taken as capsules or tablets."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "A search with the search terms (valerian or valeriana) was conducted in the databases MEDLINE and TOXLIT, via DIMDI (Cologne, Germany)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "These limitations do not allow valid extrapolations with respect to a clinical relevance of the results."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "[36]."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "[36]."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "[36]."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "[36]."}, {"generated": ["caffeine", "hydroxychlorzoxazone", "debrisoquine", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "hydroxychlorzoxazone", "debrisoquine", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "hydroxychlorzoxazone", "debrisoquine", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "hydroxychlorzoxazone", "debrisoquine", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["caffeine", "hydroxychlorzoxazone", "debrisoquine", "paraxanthine", "chlorzoxazone"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["valerian preparations"], "gold": [], "text": "A possible pharmacodynamic interaction of valerian preparations with other drugs is supported only by two case reports."}, {"generated": ["valerian"], "gold": [], "text": "That therapeutic safety regarding interactions is high in valerian and is mentioned in the respective monograph of the HMPC [18] and also in a fact sheet of the Office of Dietary Supplements at the NIH [32]."}, {"generated": ["valerian"], "gold": [], "text": "In summary, it can be concluded that warnings regarding a specific risk of interactions of valerian are without any recent evidence."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Apoio financeiro: Nenhum."}, {"generated": ["red ginseng"], "gold": [], "text": "This study aims to confirm the safety of red ginseng and herb extract complex (RHC), which are used to relieve menopausal symptoms."}, {"generated": ["white sorghum", "red shamrock", "pomegranate", "flaxseed", "red ginseng"], "gold": [], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": ["white sorghum", "red shamrock", "pomegranate", "flaxseed", "red ginseng"], "gold": [], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": ["white sorghum", "red shamrock", "pomegranate", "flaxseed", "red ginseng"], "gold": [], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": ["white sorghum", "red shamrock", "pomegranate", "flaxseed", "red ginseng"], "gold": [], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": ["white sorghum", "red shamrock", "pomegranate", "flaxseed", "red ginseng"], "gold": [], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "In addition, one subject with pruritus and hot flash and another subject with headache fully recovered after discontinuation of administration in the placebo group."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "It is noteworthy that no severe adverse reactions were observed in this study."}, {"generated": ["No herb parts mentioned in the text"], "gold": [], "text": "Furthermore, inhibition kinetic study (Dixon plot and Lineweaver-Burk plot) demonstrated that celastrol noncompetitively inhibited the UGT1A1-mediated 4-MU glucuronidation, and competitively inhibited UGT2B7-catalyzed 4-MU glucuronidation."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "When the intersection is in the second quadrant and vertical axis for Dixon and Lineweaver-Burk plots respectively, the inhibition type is competitive."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "For example, 120-fold variability of UGT1A6 expression in human liver might result in 13-fold variablity in serotonin glucuronidation [24]."}, {"generated": ["previous study"], "gold": [], "text": "The previous study performed by Du et al."}, {"generated": ["celastrol"], "gold": [], "text": "Inhibition kinetic analysis of celastrol (Cela) towards UGT2B7-catalyzed 4-MU glucuronidation."}, {"generated": ["markedly"], "gold": [], "text": "Furthermore, it decreases insulin and blood glucose markedly [17]."}, {"generated": ["Not applicable"], "gold": [], "text": "Descriptive statistics, including the frequency and percentage, and measures of central tendency and dispersion, including the mean and standard deviation (SD), were also used to describe the study variable."}, {"generated": ["herbal mixture"], "gold": [], "text": "Then, 75 participants were randomly allocated into 3 groups including group 1: CC (n = 25); group 2: herbal mixture (n = 25); and group 3: CC with herbal mixture (n = 25)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Moreover, the binary comparison indicated no significant difference in the FBS level (p = 0.212) in group 2, the insulin level (p = 0.842) in group 3, and the HOMA-IR level (p = 0.403) in group 3 compared to group 1."}, {"generated": ["medicinal plants"], "gold": [], "text": "In fact, polyphenols determine the antioxidant activity, and this positive relationship renders a trend in many medicinal plants [36]."}, {"generated": ["one herb"], "gold": [], "text": "particularly illustrated an increase in the SOD, CAT, and GPx levels, while the MDA level more significantly decreased compared to other groups using only one herb [17]."}, {"generated": ["spearmint"], "gold": [], "text": "showed that phenolic phytochemicals of spearmint possessed hypoglycemic, and antioxidant attributes [57]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "All of this research is consistent with our study."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "We recommend that further research should be undertaken regarding the effects of herbal mixtures on hormonal factors of PCOS women such as sexual hormones in both proliferative and secretory phases, and lipid profile in a longer follow-up."}, {"generated": ["essential oil"], "gold": [], "text": "Volatile compounds identified in the essential oil of herbal mixture."}, {"generated": ["V05895B"], "gold": [], "text": "V05895B; Arkopharma, Madrid, Spain)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Safety was evaluated by clinical interview and physical examination and by laboratory assessment (blood counts, chemistry, CD4+ T-cell count, and HIV-1 RNA load) on days 0, 14, and 28."}, {"generated": ["E. purpurea"], "gold": [], "text": "Figure \u200bFigure11 displays the ritonavir concentration-versus-time profile, and Table \u200bTable22 lists the pharmacokinetic parameters of ritonavir after multiple-dose administration of darunavir-ritonavir alone or in combination with E. purpurea."}, {"generated": ["Botanicals"], "gold": [], "text": "In spite of this, studies of clinical pharmacokinetic interactions between antiretroviral agents and botanicals are scarce in the literature."}, {"generated": ["EGb 761"], "gold": [], "text": "Administration of EGb 761\u00ae 120\u00a0mg b.i.d."}, {"generated": ["not specified in the text"], "gold": [], "text": "The metrics used for CYP1A2 and CYP2C9 may be considered as fully validated [28]."}, {"generated": ["not specified in the provided text"], "gold": [], "text": "does not affect CYP2C19 activity when administered over an 8-day period."}, {"generated": ["Herbal medicines"], "gold": [], "text": "The aim of this study was to systematically review data regarding pharmacokinetic (PK)-pharmacodynamic (PD) parameters from randomized controlled trials relating to interactions between herbal medicines and warfarin."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "The aim of this article was to systematically review clinical data, including PK-PD parameters, from randomized controlled trials (RCTs) and to discuss interactions between herbal medicines and warfarin."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "The search strategy for PubMed is stated below."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Type of participant."}, {"generated": ["product", "botanical source", "extract"], "gold": [], "text": "An herb was defined as a product or an extract originating from a single botanical source."}, {"generated": ["product", "botanical source", "extract"], "gold": [], "text": "An herb was defined as a product or an extract originating from a single botanical source."}, {"generated": ["product", "botanical source", "extract"], "gold": [], "text": "An herb was defined as a product or an extract originating from a single botanical source."}, {"generated": ["composition", "bioanalytical data"], "gold": [], "text": "Extraction and formulation method, composition, and bioanalytical data regarding the herbal preparations from the included RCTs are summarized Table 2."}, {"generated": ["composition", "bioanalytical data"], "gold": [], "text": "Extraction and formulation method, composition, and bioanalytical data regarding the herbal preparations from the included RCTs are summarized Table 2."}, {"generated": ["list of parts of herb used"], "gold": [], "text": "marked circle, Unclear risk of bias; Minus (-) marked circle, High risk of bias."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "All included studies investigated the PD interactions of warfarin with herbal medicines, but different parameters were used in each study."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "These relevant case reports indicated a potential herb-warfarin interaction, but it was difficult to identify a causal relationship."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "However, no studies were reported these data."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "(DOCX) Click here for additional data file."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Other diagnostic considerations in a patient presenting with coagulopathy of unknown origin include warfarin or super-warfarin exposure, disseminated intravascular coagulation (DIC), vitamin K malabsorption, and pathologic inhibitors of coagulation (6)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "This limitation applies particularly to the prediction of herb\u2013drug interactions, as herbal products are typically mixtures of multiple constituents that can alter ADME processes via multiple mechanisms."}, {"generated": ["silibinin"], "gold": [], "text": "Silibinin was selected as a model herbal product perpetrator based on well\u2010characterized composition, availability of human pharmacokinetic data, and in vitro inhibitory potency (K Because standard approaches to evaluate herb\u2013drug interactions mediated via inhibition of intestinal glucuronidation in humans have not been described, two different modeling platforms were used to predict the likelihood and magnitude of the silibinin\u2013raloxifene interaction."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Alternate study designs, including silibinin predosing and multiple dosing of raloxifene, could provide further insight into interaction potential."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Supporting Information Click here for additional data file."}, {"generated": ["Curcumin"], "gold": [], "text": "Curcumin commercially available as pure powder capsule (95%) was obtained from Quality Supplements and Vitamins (Fort Lauderdale, FL, USA)."}, {"generated": ["curcumin"], "gold": [], "text": "This effect of curcumin can be attributed due to one or more possible mechanisms as reported earlier."}, {"generated": ["other herbs/botanicals"], "gold": [], "text": "Traditional Chinese medicine accounted for most of the interactions (n = 17), followed by food (n = 10), dietary supplements (n = 3), and other herbs/botanicals (n = 3)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "2012)."}, {"generated": ["Xiao-cha-hu-tang", "Ispaghula husk"], "gold": [], "text": "Ispaghula husk, septilin, soybean and Xiao-cha-hu-tang reduced the plasma level of CBZ by affecting its gastric absorption."}, {"generated": ["Xiao-cha-hu-tang", "Ispaghula husk"], "gold": [], "text": "Ispaghula husk, septilin, soybean and Xiao-cha-hu-tang reduced the plasma level of CBZ by affecting its gastric absorption."}, {"generated": ["parts of herb"], "gold": [], "text": "Caution should also be paid for beverage containing alcohol."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["tincture", "rhizome", "capsule", "juice", "infusion", "salve", "root", "decoction", "tablet", "concoction", "gel", "essential oil", "stem", "extract", "seed", "inflorescence", "cream", "paste", "leaf", "tea", "ointment", "powder", "flower"], "gold": [], "text": "Composition of individual herbs in the included herbal formulae."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Fifty percent of the informants used herbal medicines alongside their prescription drugs."}, {"generated": ["herbal medicines"], "gold": [], "text": "In identifying these possible interactions, we have highlighted the need for healthcare professionals to promote a proactive monitoring of patients' use of herbal medicines."}, {"generated": ["None specified in the provided text"], "gold": [], "text": "A significant relationship between variables was identified if p < 0.05."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Tabular summary of the pharmacological management of the patients' based on their prescribed hypoglycaemic agents."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "For all of the 12 identified plants, pharmacological evidence validating their traditional use in diabetes management have been published."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Healthcare practitioners who are aware of their patients' use of herbal medicines and its identity can more easily monitor them for any possible interactions using available information, such as that presented in Tables 3, 4."}, {"generated": ["parts of herb"], "gold": [], "text": "Herbs have been used for primary health care for thousands of years before the advent of modern medicines."}, {"generated": ["panel of liver-specific enzymes"], "gold": [], "text": "HepaRG cell line, derived from a hepatocellular carcinoma, could express a large panel of liver-specific enzymes [5,6,7]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "A total of 22 compounds were identified or tentatively identified (Figure 1)."}, {"generated": ["PON"], "gold": [], "text": "The influence test for PON was conducted by the method of Furlong et al."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "** and *** denoted result significantly different from that of the control group (p < 0.01 and p < 0.001, respectively)."}, {"generated": ["Banderol", "Samento"], "gold": [], "text": "Neither Samento nor Banderol increased intracellular calcein fluorescence in L-MDR1 cells over-expressing human P-glycoprotein (P-gp), indicating lack of P-gp inhibition (data not shown)."}, {"generated": ["Banderol", "Samento"], "gold": [], "text": "Neither Samento nor Banderol increased intracellular calcein fluorescence in L-MDR1 cells over-expressing human P-glycoprotein (P-gp), indicating lack of P-gp inhibition (data not shown)."}, {"generated": ["Data"], "gold": [], "text": "Data were evaluated as described previously [28]."}, {"generated": ["Banderol", "Samento"], "gold": [], "text": "IC In conclusion, Samento and Banderol exhibit a completely different in vitro profile as perpetrators in herb\u2013drug interactions."}, {"generated": ["Banderol", "Samento"], "gold": [], "text": "IC In conclusion, Samento and Banderol exhibit a completely different in vitro profile as perpetrators in herb\u2013drug interactions."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Thanks to J. Kocher, S. Rosenzweig, C. Mueller, A. Fautsch, and T. R\u00fctzert for excellent technical assistance, to D. Ballinari (Pharmacia & Upjohn, Milano, Italy) for providing P388 and P388/dx cells, to A. H. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) for providing MDCKII-BCRP cells, to D. Keppler (German Cancer Research Centre, Heidelberg, Germany) for providing HEK-OATP1B1 and HEK-OATP1B3 cell lines, to Z. Dvorak (Palyck\u00fd University, Olomouc, Czech Republic) for providing the AZ-AhR cells, and to D. Theile for careful proofreading of the manuscript."}, {"generated": ["parts of herb"], "gold": [], "text": "* p < 0.05, ** p < 0.01."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Results of the reporter gene assays."}, {"generated": ["Samento"], "gold": [], "text": "Effect of Samento on CYP2J2 mRNA decay in LS180 cells."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Its original formulation was in a tablet form."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Subjects were also asked to abstain from taking prescription and over the counter medications for 2 weeks before and during the study period."}, {"generated": ["4-hydroxybupropion", "bupropion"], "gold": [], "text": "Geometric means were calculated for the AUC(0,\u221e), Cmax and so on of bupropion and 4-hydroxybupropion."}, {"generated": ["4-hydroxybupropion", "bupropion"], "gold": [], "text": "Geometric means were calculated for the AUC(0,\u221e), Cmax and so on of bupropion and 4-hydroxybupropion."}, {"generated": ["woohwangcheongsimwon suspension"], "gold": [], "text": "Go to: Discussion  In this study, we examined the CYP2B6 inhibitory effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion."}, {"generated": ["pomegranate", "grapefruit"], "gold": [], "text": "The herbal reaction toward different types of statins is varied so that grapefruit or pomegranate was interacted with only some types of statins, but not with all statin types."}, {"generated": ["pomegranate", "grapefruit"], "gold": [], "text": "The herbal reaction toward different types of statins is varied so that grapefruit or pomegranate was interacted with only some types of statins, but not with all statin types."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Inhibition and/or induction of drug-metabolizing enzymes (DME) and or drug transporters mediated by herbs is the most typical mechanism of herb-drug interactions, which in turn alters the pharmacokinetic disposition of the drug [24,25]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "and M.A.A."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "; supervision, K.M.A."}, {"generated": ["List of parts of herb used"], "gold": [], "text": "All authors have read and agreed to the published version of the manuscript."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "All results are presented as the average \u00b1 SD."}, {"generated": ["DAS"], "gold": [], "text": "Hepatic (A) and intestinal (B) BCRP/ABCG2 protein expression in rats after DAS administration with or without APG pretreatment."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Phytochemical-mediated modulation of cytochrome P-450 (CYP) activity may underlie many herb-drug interactions."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "If so, herb-mediated changes in CYP activity may take on greater clinical relevance in this population."}, {"generated": ["botanical supplements"], "gold": [], "text": "Concomitant ingestion of botanical supplements with prescription medications, therefore, should be strongly discouraged in the elderly."}, {"generated": ["SC extract"], "gold": [], "text": "The purpose of this study was to evaluate the effect of SC extract supplementation on quadriceps muscle strength (QMS) and lactate at rest in adult women."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "In the main test session, subjects performed 5 isokinetic knee extensions of the leg at an angular velocity of 60 degrees/second, and subjects recovered passively for 2 min between sets of measurements [26,27]."}, {"generated": ["St. John's wort"], "gold": [], "text": "The first clinically relevant reports of preparations of St. John's wort (SJW), a herbal medicine with anti\u2010depressant effects, interacting with other drugs, altering their bioavailability and efficacy, were published about 20 years ago."}, {"generated": ["None"], "gold": [], "text": "These interactions were caused by pregnane\u2010X\u2010receptor (PXR) activation."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "The most important information has been comprehensively summarized (Borrelli & Izzo, 2009; Chrubasik\u2010Hausmann, Vlachojannis, & McLachlan, 2019; Gurley, Fifer, & Gardner, 2012; Izzo, 2004; Soleymani, Bahramsoltani, Rahimi, & Abdollahi, 2017; Whitten, Myers, Hawrelak, & Wohlmuth, 2006)."}, {"generated": ["extracts", "hyperforin", "flavonoids", "hypericin", "isolated constituents"], "gold": [], "text": "SJW extracts as well as isolated constituents (hyperforin, hypericin, or flavonoids) have been investigated in vitro and in vivo for their interactions with a variety of potentially relevant targets for depression."}, {"generated": ["extracts", "hyperforin", "flavonoids", "hypericin", "isolated constituents"], "gold": [], "text": "SJW extracts as well as isolated constituents (hyperforin, hypericin, or flavonoids) have been investigated in vitro and in vivo for their interactions with a variety of potentially relevant targets for depression."}, {"generated": ["extracts", "hyperforin", "flavonoids", "hypericin", "isolated constituents"], "gold": [], "text": "SJW extracts as well as isolated constituents (hyperforin, hypericin, or flavonoids) have been investigated in vitro and in vivo for their interactions with a variety of potentially relevant targets for depression."}, {"generated": ["extracts", "hyperforin", "flavonoids", "hypericin", "isolated constituents"], "gold": [], "text": "SJW extracts as well as isolated constituents (hyperforin, hypericin, or flavonoids) have been investigated in vitro and in vivo for their interactions with a variety of potentially relevant targets for depression."}, {"generated": ["extracts", "hyperforin", "flavonoids", "hypericin", "isolated constituents"], "gold": [], "text": "SJW extracts as well as isolated constituents (hyperforin, hypericin, or flavonoids) have been investigated in vitro and in vivo for their interactions with a variety of potentially relevant targets for depression."}, {"generated": ["hyperforin"], "gold": [], "text": "This statement was provided even before another comprehensive pharmacokinetic interaction study was published, where no clinically relevant interactions were found for seven test drugs in concomitant application with a low\u2010hyperforin SJW extract (Zahner et al., 2019)."}, {"generated": ["Lingzhi", "Yunzhi"], "gold": [], "text": "Although systematic reviews and meta-analysis of Lingzhi and Yunzhi as an adjunct for cancer treatment have been performed [8\u201310], these reviews mostly focused on clinical outcomes with no mechanistic explanations for the potential beneficial or harmful interactions."}, {"generated": ["Lingzhi", "Yunzhi"], "gold": [], "text": "Although systematic reviews and meta-analysis of Lingzhi and Yunzhi as an adjunct for cancer treatment have been performed [8\u201310], these reviews mostly focused on clinical outcomes with no mechanistic explanations for the potential beneficial or harmful interactions."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "If the control group also received medicinal mushrooms, there should be significant dosage differences of the mushrooms in the treatment group."}, {"generated": ["medicinal mushrooms"], "gold": [], "text": "Reduce T cell apoptosis and caspase 3 activity through downregulating Bax expression in T cells [170] Increase in efficacy and survival [20], better symptomatic relief [20] increase in T cells count (CD4, CD4/CD8) [20] Better symptomatic relief [141] and increase appetite [144] Less reduction in WBC (CD3+, CD4+ T cells, NK cells) [141, 144], platelets [144] Pharmacodynamic interactions between medicinal mushrooms and cytotoxic drugs in preclinical studies Increase in tumor inhibition effect [83, 84, 98] and survival time [63] Less decrease in WBC [83, 84, 145], platelets [83] and other bone marrow cells [84] Greater recovery rate from intestinal damage caused by 5-FU [173] Increase in survival [67], cytotoxicity and inhibit metastasis [111] Reduce immunosuppression (reduce the decrease in phagocytic activity, antibody production [111], delayed hypersensitivity [111, 112]) Increase in tumor inhibition and apoptotic rate (dose-related or time-dependent) [98\u2013103], similar effect at lower dose of 5-FU [105] Induce cell cycle arrest at different phases [99, 101], increase caspase 3 and 8 expression and activity [100]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "In addition, the enhancement of the antitumor effect was shown to be achieved via the inhibition of tumor cell angiogenesis [104] or increase in the reactive oxygen species production [124]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Notably, a recent study found that such synergistic effect may be due to the inhibition of tumor metabolism via down-regulating Warburg-related proteins and restoration of the gut dysbiosis induced by paclitaxel [97]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "a."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Table S4."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: All."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Not applicable."}, {"generated": ["Not applicable"], "gold": [], "text": "Approximately 70\u201380% of all breast tumors are estrogen receptor (ER) positive [2], and hormonal therapy plays therefore an important role in the therapy of early stage and metastatic ER-positive breast cancer."}, {"generated": ["Viscum album"], "gold": [], "text": "Clinical studies have reported on the benefits of Viscum album extracts (VAE) not only in breast cancer patients but also for other types of cancer [10\u201313]."}, {"generated": ["total mistletoe"], "gold": [], "text": "5\u2009mg (VAEM, host tree Malus domestica, Lot 7054/0, total mistletoe lectin concentration 306\u2009ng/mL), and Iscador Qu spec."}, {"generated": ["dextrorphan-d", "4-hydroxy-N-desmethyltamoxifen hydrochloride", "\u03b2-estradiol"], "gold": [], "text": "(E/Z)-endoxifen hydrochloride (4-hydroxy-N-desmethyltamoxifen hydrochloride), \u03b2-estradiol (E2) and dextrorphan-d Pooled human liver microsomes (HLMs, 50 donors, mixed gender) were purchased from Bioreclamation IVT (Baltimore, USA)."}, {"generated": ["dextrorphan-d", "4-hydroxy-N-desmethyltamoxifen hydrochloride", "\u03b2-estradiol"], "gold": [], "text": "(E/Z)-endoxifen hydrochloride (4-hydroxy-N-desmethyltamoxifen hydrochloride), \u03b2-estradiol (E2) and dextrorphan-d Pooled human liver microsomes (HLMs, 50 donors, mixed gender) were purchased from Bioreclamation IVT (Baltimore, USA)."}, {"generated": ["dextrorphan-d", "4-hydroxy-N-desmethyltamoxifen hydrochloride", "\u03b2-estradiol"], "gold": [], "text": "(E/Z)-endoxifen hydrochloride (4-hydroxy-N-desmethyltamoxifen hydrochloride), \u03b2-estradiol (E2) and dextrorphan-d Pooled human liver microsomes (HLMs, 50 donors, mixed gender) were purchased from Bioreclamation IVT (Baltimore, USA)."}, {"generated": ["pooled micromsomes"], "gold": [], "text": "The significant inter-individual variability of CYP2D6 activity due to genetic polymorphisms was mitigated by the use of pooled microsomes from 50 donors [41]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "(PDF 36 kb) Figure S2."}, {"generated": ["H. sabdariffa"], "gold": [], "text": "To our knowledge, there is no available information regarding pharmacokinetic interactions between captopril and H. sabdariffa."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "In selectivity testing, six rats plasma was used."}, {"generated": ["H. sabdariffa extract"], "gold": [], "text": "Two weeks of coadministration of H. sabdariffa extract is sufficient enough to affect the GSH level or the expression of the PEPT1 transporter."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "2016; Eng et\u00a0al."}, {"generated": ["root"], "gold": [], "text": "2016)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "HOW MIGHT THIS CHANGE CLINICAL PHARMACOLOGY OR TRANSLATIONAL SCIENCE?"}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "(n\u00a0=\u00a06)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "S.M., Y.O., R.T., E.H., T.O., H.O., and K.S."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "S.M., Y.O., R.T., J.K., H.W., M.F., and K.S."}, {"generated": ["Eugenia jambolana"], "gold": [], "text": "Eugenia jambolana (EJ) is an Indian traditional herb widely used for the treatment of diabetes mellitus."}, {"generated": ["filtered", "filtrate"], "gold": [], "text": "It was filtered and the filtrate obtained in this step was mixed with the previous filtrate."}, {"generated": ["filtered", "filtrate"], "gold": [], "text": "It was filtered and the filtrate obtained in this step was mixed with the previous filtrate."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "3a and b)."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "3a and b)."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "3a and b)."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "3a and b)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Mass chromatograms of SITA and PRM (Peak for SITA at 0.642min, PRM at 0.482\u202fmin)."}, {"generated": ["No herb parts mentioned in the text provided"], "gold": [], "text": "Values expressed as mean\u00a0\u00b1\u00a0SEM of six rats."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "*significantly different from normal group, # significantly different from diabetic control group at p\u00a0<\u00a00.001."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Treatment with EJE and EJE\u202f+\u202fSITA significantly (p\u202f<\u202f0.001) reduced the elevated levels of BUN (Fig."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "9, Table\u00a02)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "*significantly different from normal group, # significantly different from diabetic control group at p\u00a0<\u00a00.001."}, {"generated": ["Officinarum"], "gold": [], "text": "A.\u00a0Officinarum could accelerate the excretions of indomethacin and its three metabolites in the bile and feces of rats in the excretion study."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "1)."}, {"generated": ["dong quai", "root", "ginkgo", "leaf"], "gold": [], "text": "or other herbs (Danshen, Ginkgo biloba, Dong quai, etc.)."}, {"generated": ["dong quai", "root", "ginkgo", "leaf"], "gold": [], "text": "or other herbs (Danshen, Ginkgo biloba, Dong quai, etc.)."}, {"generated": ["dong quai", "root", "ginkgo", "leaf"], "gold": [], "text": "or other herbs (Danshen, Ginkgo biloba, Dong quai, etc.)."}, {"generated": ["dong quai", "root", "ginkgo", "leaf"], "gold": [], "text": "or other herbs (Danshen, Ginkgo biloba, Dong quai, etc.)."}, {"generated": ["Gouqizi"], "gold": [], "text": "In China, Gouqizi is a popular component of the daily diet, making the prohibition of its consumption in patients taking warfarin difficult to implement."}, {"generated": ["Lycium barbarum"], "gold": [], "text": "The interaction study of warfarin and Lycium barbarum L.  Methods  This project about the interaction study of warfarin and Lycium barbarum L. is approved by Fujian Medical University Union Hospital ethics committee (NO: 2015KY002)."}, {"generated": ["HS extract"], "gold": [], "text": "Animal studies have consistently shown that consumption of HS extract reduces blood pressure in a dose dependent manner."}, {"generated": ["aqueous extracts"], "gold": [], "text": "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside, are generally believed to be the active constituents responsible for the antihypertensive, antioxidant, and hypocholesterolemic effects of HS, possibly because they are found in high relative quantities in aqueous extracts [8, 11, 13, 16]."}, {"generated": ["deeper red calyxes"], "gold": ["calyxes"], "text": "The HS varieties with deeper red calyxes exhibited greater antioxidant activity as compared to lighter red or white varieties [44, 45]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "7.2."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Table 5  Cholesterol RCT interventions and effects of cholesterol RCT interventions on total cholesterol, HDL-C, LDL-C, and triglycerides."}, {"generated": ["HS"], "gold": [], "text": "One brief 15 day study reported a significant increase in total cholesterol among hypertensive patients administered HS [18]."}, {"generated": ["HS"], "gold": [], "text": "Studies demonstrate that HS consumption does not adversely effect liver and kidney function at lower doses, but may be hepatotoxic at extremely high doses."}, {"generated": ["HS extract"], "gold": [], "text": "In addition, electrolyte levels generally are not effected by ingesting HS extracts despite its diuretic effects."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "As a service to our customers we are providing this early version of the manuscript."}, {"generated": ["Schisandra lignans"], "gold": [], "text": "Interaction between imatinib and Schisandra lignans was unlikely to be of clinical importance."}, {"generated": ["not specified"], "gold": [], "text": "21 Clearly, a reliable and systematic approach to predict these herb\u2013drug interactions is needed."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Go to: 2."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "2.1.2."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "8 Partition coefficients (log P) of neutral compounds are generally the most influential parameter dictating the extent of distribution to different tissues."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "capsule", "fluid extract", "oil", "infusion", "solution", "root", "decoction", "plaster", "tablet", "concoction", "essence", "gel", "stem", "extract", "paste", "leaf", "tea", "poultice", "ointment", "topical cream", "suppository", "seeds", "bark", "powder", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["Schisandra"], "gold": [], "text": "Another limitation of the current study is the reliance on the assumption that Schisandra lignans are solely responsible for the interactions with CYP substrates."}, {"generated": ["No herb parts mentioned in the text"], "gold": [], "text": "Microsomes incubation, Real Time-Polymerase Chain Reaction and Western blot was applied respectively to study the activity, mRNA expression and protein expression of CYP, VKOR and TM."}, {"generated": ["Danshen"], "gold": [], "text": "We also monitored the effects of Danshen/Gegen on the activities and mRNA and protein expression levels of VKOR and TM (for pharmacodynamic analysis)."}, {"generated": ["naringin"], "gold": [], "text": "The plant names in current study were used according to the latest revision in \u201cThe Plant List\u201d ( Racemic warfarin, diclofenac sodium and naringin (internal standards) were purchased from Sigma-Aldrich (St. Louis, MO, USA)."}, {"generated": ["Danshen"], "gold": [], "text": "Furthermore, no inductive effects were observed in the mRNA expression level of CYP2C6 for both doses of Danshen compared with the vehicle control group."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "*P\u00a0<\u00a00.05; **P\u00a0<\u00a00.01; ***P\u00a0<\u00a00.001, compared with the vehicle control group."}, {"generated": ["Gegen", "Danshen"], "gold": [], "text": "Danshen and Gegen elicit their effects by improving microcirculation and inhibiting platelet aggregation [24, 32], whereas warfarin exerts its anticoagulant effect by inhibiting the activity of VKOR and inducing TM."}, {"generated": ["Gegen", "Danshen"], "gold": [], "text": "Danshen and Gegen elicit their effects by improving microcirculation and inhibiting platelet aggregation [24, 32], whereas warfarin exerts its anticoagulant effect by inhibiting the activity of VKOR and inducing TM."}, {"generated": ["Gegen"], "gold": [], "text": "Taken together with the results of the current study, it seems clear that these effects could be attributed to the Gegen present in DFG."}, {"generated": ["Danshen"], "gold": [], "text": "This finding is also supported by Yueng\u2019s study, where the major tanshinone components rather than the aqueous extract of Danshen showed effects on warfarin hydroxylation in vitro and in vivo [58]."}, {"generated": ["SAB"], "gold": [], "text": "In our study, although SAB was used as a major component of the Danshen granules, the in vivo effects were very different to those observed in cells because of the poor absorption and bioavailability of SAB."}, {"generated": ["Danshen"], "gold": [], "text": "liver cytochrome P450 vitamin K epoxide reductase vitamin K vitamin K thrombomodulin Danshen\u2013Gegen Formula salvianolic acid B phenobarbital beta-naphthoflavone cyclophosphamide enzyme-linked immunosorbent assay Beikang Ge and Zhen Zhang contributed equally to this work BKG, ZZh and ZZu conceived and designed the study."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Competing interests          The authors have declared no conflicts of interests."}, {"generated": ["tropical medicinal herbs"], "gold": [], "text": "Little is known of the effect of most tropical medicinal herbs on the metabolic capacity of CYP isoenzymes."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Each mixture was filtered, concentrated, and freeze\u2010dried."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Positive controls (see Supporting Information data, Table S1), CYP isoenzymes inhibited, and concentration used in the N\u2010in\u2010one assay are as reported in the validated methods (Turpeinen et\u00a0al., 2005; Tolonen et\u00a0al., 2007; Showande et\u00a0al., 2013)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Fifty percent inhibitory concentration (IC   where A\u00a0=\u00a0log of concentration of aqueous extract of herb in the incubations."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "In vitro herb\u2013drug interactions studies are mostly conducted for commonly used herbs to evaluate and predict potentially significant in vivo herb\u2013drug interactions and to help design appropriate in vivo herb\u2013drug interaction studies (Fasinu, Bouic, & Rosenkranz, 2012; Awortwe, Bouic, Masimirembwa, & Rosenkranz, 2013)."}, {"generated": ["Allium sativum bulbs"], "gold": ["bulbs"], "text": "In this study, aqueous extract of oven\u2010dried Allium sativum bulbs was used."}, {"generated": ["Moringa oleifera leaves"], "gold": ["leaves"], "text": "Aqueous extract of Moringa oleifera leaves showed weak inhibition of CYP1A2 and CYP2C9."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Strandell et\u00a0al."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "(2000)."}, {"generated": ["polyherbal formulation"], "gold": [], "text": "Ltd., Varanasi, India) is a patented polyherbal formulation developed to manage menopause symptoms that can be taken along with other allopathic medicines."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "34860-2.5L-R) and ammonium acetate (catalog No."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "The following formula determines the half-maximal inhibitory concentration (IC SRM Medical College Hospital and Research Centre and SRM Institute of Science and Technology, Kattankulathur ethics committees approved the protocol (approval No."}, {"generated": ["Simvastatin", "Simvastatin hydroxy acid", "Lovastatin"], "gold": [], "text": "The mean (SD) plasma concentrations of simvastatin, its metabolite simvastatin hydroxy acid, and internal standard lovastatin are shown in Figure\u00a04."}, {"generated": ["Simvastatin", "Simvastatin hydroxy acid", "Lovastatin"], "gold": [], "text": "The mean (SD) plasma concentrations of simvastatin, its metabolite simvastatin hydroxy acid, and internal standard lovastatin are shown in Figure\u00a04."}, {"generated": ["Simvastatin", "Simvastatin hydroxy acid", "Lovastatin"], "gold": [], "text": "The mean (SD) plasma concentrations of simvastatin, its metabolite simvastatin hydroxy acid, and internal standard lovastatin are shown in Figure\u00a04."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Values are expressed as mean (SD)."}, {"generated": ["parts of herb"], "gold": [], "text": "A difference was considered significant at P < 0.05."}, {"generated": ["herbal medicines", "herbal formulations"], "gold": [], "text": "Herb-drug interactions incidence was predicted to increase due to herbal medicines' worldwide popularity with the development of several herbal formulations with improved bioavailability."}, {"generated": ["herbal medicines", "herbal formulations"], "gold": [], "text": "Herb-drug interactions incidence was predicted to increase due to herbal medicines' worldwide popularity with the development of several herbal formulations with improved bioavailability."}, {"generated": ["several herbal supplementations"], "gold": [], "text": "Case Report: Fatigue and Bleeding in a Polymedicated Patient Using Several Herbal Supplementations, Detected with g-Nomic\u00ae Software Abel Saldarreaga Marin, 1 Marc Cendros, 2 Carlos J Ciudad, 3 and Ana Sabater 2 Author information Article notes Copyright and License information PMC Disclaimer Go to: Abstract  This was a case report of severe fatigue and bleeding in a 65-year-old man with ischemic heart disease who was wearing a stent and taking multiple medications for hypertension and diabetes."}, {"generated": ["echinacea", "policosanol"], "gold": [], "text": "Therefore, two commonly used herbal medicines, echinacea and policosanol were investigated for their potential to interact with warfarin."}, {"generated": ["echinacea", "policosanol"], "gold": [], "text": "Therefore, two commonly used herbal medicines, echinacea and policosanol were investigated for their potential to interact with warfarin."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "All subjects completed the study and no adverse events related to either of the herbal medicines or warfarin were reported."}, {"generated": ["echinacea"], "gold": [], "text": "Table 3  Platelet aggregation (Ohms) after 2 weeks of echinacea and policosanol pre-treatment (n= 12) \tControl\tPolicosanol treatment\tEchinacea treatment Agonist\tMean (95% CI)\tMean (95% CI)\tGeometric mean ratio to control (90% CI)\tMean (95% CI)\tGeometric mean ratio to control (90% CI) ADP*\t7.8 (5.5, 10.0)\t6.8 (4.9, 8.8)\t0.92 (0.64, 1.30)\t7.5 (4.1, 10.8)\t0.84 (0.59, 1.19) Arachidonic acid\t11.0 (9.6, 12.5)\t11.2 (9.4, 12.9)\t1.00 (0.82, 1.23)\t12.1 (9.3, 15.0)\t1.06 (0.86, 1.30) Collagen\t13.0 (11.5, 14.6)\t14.9 (12.6, 17.2)\t1.13 (0.93, 1.37)\t15.8 (12.2, 19.5)\t1.17 (0.97, 1.42) Open in a separate window *Adenosine diphosphate."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Interestingly, this effect on the pharmacokinetics of (S)-warfarin was not associated with a significant effect on warfarin pharmacodynamics."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Gorski et al."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "A survey of cancer patients attending the oncology and urology clinics at the University Hospital of the West Indies in Kingston, and two earlier surveys of Jamaican prescription drug users identified high levels of herb-drug use (80% [4] 80% [5] and 81% [6], respectively), while awareness of such herb-drug use amongst health care professionals was low across all four surveys (13% [5], 15% [4], 18% [6] and 19% [3], respectively)."}, {"generated": ["Ginkgo biloba", "Panax ginseng", "Allium sativum", "Hypericum perforatum"], "gold": [], "text": "Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John\u2019s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9]."}, {"generated": ["Ginkgo biloba", "Panax ginseng", "Allium sativum", "Hypericum perforatum"], "gold": [], "text": "Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John\u2019s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9]."}, {"generated": ["Ginkgo biloba", "Panax ginseng", "Allium sativum", "Hypericum perforatum"], "gold": [], "text": "Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John\u2019s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9]."}, {"generated": ["Ginkgo biloba", "Panax ginseng", "Allium sativum", "Hypericum perforatum"], "gold": [], "text": "Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John\u2019s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9]."}, {"generated": ["Key phytochemicals"], "gold": [], "text": "Key phytochemicals were individually assessed for their impact on CYP1A2 activity."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "The IC It was not possible to determine the IC In vitro CYP assays offer an accurate, and relatively inexpensive, first stage assessment tool for gauging the potential for herb-drug interactions."}, {"generated": ["lignans", "cadinol", "beta-sitosterol"], "gold": [], "text": "\u03b2-Sitosterol, cadina-4,10(15)-dien-3-one and a mix of five lignans comprised of dehydropodophyllotoxin, deoxydehydropodophyllotoxin, 4\u2032-demethyldesoxypodophyllotoxin, 5\u2032-methoxydehydropodophyllotoxin, and dehydro-b-peltatin methyl ether were supplied by the Department of Chemistry, University of the West Indies, Mona Campus, Jamaica."}, {"generated": ["lignans", "cadinol", "beta-sitosterol"], "gold": [], "text": "\u03b2-Sitosterol, cadina-4,10(15)-dien-3-one and a mix of five lignans comprised of dehydropodophyllotoxin, deoxydehydropodophyllotoxin, 4\u2032-demethyldesoxypodophyllotoxin, 5\u2032-methoxydehydropodophyllotoxin, and dehydro-b-peltatin methyl ether were supplied by the Department of Chemistry, University of the West Indies, Mona Campus, Jamaica."}, {"generated": ["lignans", "cadinol", "beta-sitosterol"], "gold": [], "text": "\u03b2-Sitosterol, cadina-4,10(15)-dien-3-one and a mix of five lignans comprised of dehydropodophyllotoxin, deoxydehydropodophyllotoxin, 4\u2032-demethyldesoxypodophyllotoxin, 5\u2032-methoxydehydropodophyllotoxin, and dehydro-b-peltatin methyl ether were supplied by the Department of Chemistry, University of the West Indies, Mona Campus, Jamaica."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "The following chromatographic methods were employed."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "[15] to screen natural products for cytochrome P450 inhibition potential with a particular emphasis on the P450 enzymes, CYPs 1A1, 1A2, 1B1, 3A4 and 2D6."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "[35]."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "[35]."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "[35]."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "[35]."}, {"generated": ["Not applicable"], "gold": [], "text": "100 \u00b5L of various concentrations of the extracts, and the ascorbic acid control, in methanol, were added to 100 \u00b5L of a 0.02% (w/v) stock solution of the free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) in methanol."}, {"generated": ["aerial", "dried"], "gold": ["aerial"], "text": "Structures of phytochemicals identified in the aqueous extract of H. verticillata (aerial, dried)."}, {"generated": ["curcumin"], "gold": [], "text": "The pharmacokinetic data revealed that curcumin-treated animals had significantly (p \u2264 0.05) higher area under the plasma concentration-time curve and area under the first moment of plasma drug concentration-time curve."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Worse than the Disease?"}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["tincture", "root", "decoction", "stem", "extract", "capsule", "topical preparation", "tablet", "essence", "oil", "infusion", "leaf", "suppository", "seeds", "bark", "poultice", "flower"], "gold": [], "text": "An external file that holds a picture, illustration, etc."}, {"generated": ["all the herb/herbal components"], "gold": [], "text": "The formation rate of OSA could be significantly suppressed by all the herb/herbal components."}, {"generated": ["anti-influenza herbs/herbal components"], "gold": [], "text": "S4, the P The above in-vitro experiments suggested that there should be some potential HDI between OS and these anti-influenza herbs/herbal components during absorption and metabolism."}, {"generated": ["RS"], "gold": [], "text": "The results suggested that co-administration with RS could significantly increase the systemic exposure of OS and decrease that of OSA (Fig."}, {"generated": ["RS"], "gold": [], "text": "This can further be verified by the lowered OSA/OS ratio in rat urine samples after co-administration with RS (Fig."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "S8)."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "S8)."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "S8)."}, {"generated": ["root", "leaf", "flower", "seeds"], "gold": [], "text": "S8)."}, {"generated": ["potential interaction", "anti-influenza herb/herbal components"], "gold": [], "text": "In our current study, a screening platform based on microsomes, enzymes, cells and influenza viruses have for the first time been developed and utilized to screen potential interaction between OS and anti-influenza herb/herbal components."}, {"generated": ["potential interaction", "anti-influenza herb/herbal components"], "gold": [], "text": "In our current study, a screening platform based on microsomes, enzymes, cells and influenza viruses have for the first time been developed and utilized to screen potential interaction between OS and anti-influenza herb/herbal components."}, {"generated": ["herbal extracts", "herbal components"], "gold": [], "text": "The metabolic inhibition studies performed in rat plasma suggested that all the herbal extracts (500\u202f\u03bcg/mL) and all the herbal components (100\u202f\u03bcg/mL) could inhibit the hydrolysis of OS in rat plasma, but the % inhibition rate varied between herbs/herbal components."}, {"generated": ["herbal extracts", "herbal components"], "gold": [], "text": "The metabolic inhibition studies performed in rat plasma suggested that all the herbal extracts (500\u202f\u03bcg/mL) and all the herbal components (100\u202f\u03bcg/mL) could inhibit the hydrolysis of OS in rat plasma, but the % inhibition rate varied between herbs/herbal components."}, {"generated": ["not specified"], "gold": [], "text": "The hydrolase activities in rat plasma may be originated from more than one kind of enzymes (not only hCE1) and the inhibition activities of these herbal components to each kind of hydrolysis enzymes are different."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "After such a normalization, the absolute z-score of an herb/herbal component effect on OS would be proportional to its level of HDI relevancy with OS."}, {"generated": ["RS"], "gold": [], "text": "As shown in Table 1, after co-administration with RS, BIO of OS increased by 62% without change in its absorption rate (k  The developed pop-PK model lets us have an interpretation on the contradictory phenomena that co-administration of RS would increase both the elimination rate and systemic exposure (AUC The pop-PK model could separately estimate the metabolic clearance (CL  A platform including a six-dimension in-vitro screening, an in-vivo pharmacokinetics in rats and an ex-vivo pharmacodynamic evaluation, has been developed and successfully applied to find RS as a potential herb that would influence the co-administrated OS in rats."}, {"generated": ["Root of Isatis indigotica"], "gold": ["Root"], "text": "Radix Isatidis (Root of Isatis indigotica Fort., Banlangen)."}, {"generated": ["Fruit of Arctium lappa L., Niubangzi"], "gold": ["Fruit"], "text": "Fructus Arctii (Fruit of Arctium lappa L., Niubangzi)."}, {"generated": ["Not specified in the text"], "gold": [], "text": "30%\u201370% of clinical breast cancer patients use natural products, which may increase the likelihood of drug interactions."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Conclusion: There is evidence for potential interactions of various natural products with TAM in pre-clinical studies, although the relevant clinical evidence is still lacking."}, {"generated": ["Phellodendron bark", "dried orange peel", "Anemarrhena"], "gold": [], "text": "), dried orange peel (Citrus aurantium L.), Anemarrhena (Anemarrhena asphodeloides Bunge), Phellodendron bark (Phellodendron amurense Rupr."}, {"generated": ["Phellodendron bark", "dried orange peel", "Anemarrhena"], "gold": [], "text": "), dried orange peel (Citrus aurantium L.), Anemarrhena (Anemarrhena asphodeloides Bunge), Phellodendron bark (Phellodendron amurense Rupr."}, {"generated": ["Phellodendron bark", "dried orange peel", "Anemarrhena"], "gold": [], "text": "), dried orange peel (Citrus aurantium L.), Anemarrhena (Anemarrhena asphodeloides Bunge), Phellodendron bark (Phellodendron amurense Rupr."}, {"generated": ["Stems", "Leaves", "Roots", "Seeds", "Flowers"], "gold": [], "text": "), Licorice (Glycyrrhiza glabra L.), Ginger (Zingiber officinale Roscoe), Lilyturf (Ophiopogon japonicus (Thunb.)"}, {"generated": ["Stems", "Leaves", "Roots", "Seeds", "Flowers"], "gold": [], "text": "), Licorice (Glycyrrhiza glabra L.), Ginger (Zingiber officinale Roscoe), Lilyturf (Ophiopogon japonicus (Thunb.)"}, {"generated": ["Stems", "Leaves", "Roots", "Seeds", "Flowers"], "gold": [], "text": "), Licorice (Glycyrrhiza glabra L.), Ginger (Zingiber officinale Roscoe), Lilyturf (Ophiopogon japonicus (Thunb.)"}, {"generated": ["Stems", "Leaves", "Roots", "Seeds", "Flowers"], "gold": [], "text": "), Licorice (Glycyrrhiza glabra L.), Ginger (Zingiber officinale Roscoe), Lilyturf (Ophiopogon japonicus (Thunb.)"}, {"generated": ["Stems", "Leaves", "Roots", "Seeds", "Flowers"], "gold": [], "text": "), Licorice (Glycyrrhiza glabra L.), Ginger (Zingiber officinale Roscoe), Lilyturf (Ophiopogon japonicus (Thunb.)"}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "The key mechanisms of action of anti-cancer drugs involve apoptosis, autophagy, and cell cycle arrest (Chen and Karantza-Wadsworth, 2009; Wang et el., 2011; Kon et al., 2013)."}, {"generated": ["Mistletoe"], "gold": [], "text": "Mistletoe (Viscum album L.) derived medicinal preparations are widely used and registered as medicines in many European countries."}, {"generated": ["12 traditional herbs"], "gold": [], "text": "Jaeumkanghwa soup (JEKHT) is a compound composed of 12 traditional herbs (Jung et al., 2010)."}, {"generated": ["Jiawei Xiaoyao San"], "gold": [], "text": "Jiawei Xiaoyao San (JWXYS) is a very common Chinese herbal formula used by the Chinese for thousands of years (Chen et al., 2014)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "The protective effect is dose-dependent (Rahate and Rajasekaran, 2015)."}, {"generated": ["Chinese herbal plant"], "gold": [], "text": "ex D. Don (P. capitatum), a Chinese herbal plant, is often used alone or in combination with antibacterial agents to treat urinary tract infections, pyelonephritis, and prostatitis in China (Chinese Pharmacopoeia Commission, 2010; Liao et al., 2011)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Consequently, GA and PCA were chosen as PCE tracer components in the pharmacokinetic- and tissue distribution-based HDIs studies."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "CIP significantly increased the K  Tissue distribution profiles of gallic acid (GA) after oral administration of PCE in the absence (A) and presence (B) of ciprofloxacin, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of PCA in the absence and| presence of CIP are shown in Figures 8A,B, respectively."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Click here for additional data file."}, {"generated": ["Not specified in the provided text"], "gold": [], "text": "The scale was anchored at each end with the labels \u201cnot at all\u201d (0 mm) and \u201cextremely\u201d (100 mm)."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "This increase is comparable with 24% increase found during low to moderate exercise intensities determined using an incremental protocol in our previous study [22]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Co., Seoul, Korea) and their identity was kindly confirmed by Prof. Yeong Bae Seo (a specialist in plant classification, Natural Products Research Institute, Seoul National University, Seoul, Korea)."}, {"generated": ["OCT1", "OAT3", "OATP1B1", "OAT1", "OATP1B3", "OCT2"], "gold": [], "text": "[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA)."}, {"generated": ["OCT1", "OAT3", "OATP1B1", "OAT1", "OATP1B3", "OCT2"], "gold": [], "text": "[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA)."}, {"generated": ["OCT1", "OAT3", "OATP1B1", "OAT1", "OATP1B3", "OCT2"], "gold": [], "text": "[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA)."}, {"generated": ["OCT1", "OAT3", "OATP1B1", "OAT1", "OATP1B3", "OCT2"], "gold": [], "text": "[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA)."}, {"generated": ["OCT1", "OAT3", "OATP1B1", "OAT1", "OATP1B3", "OCT2"], "gold": [], "text": "[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA)."}, {"generated": ["OCT1", "OAT3", "OATP1B1", "OAT1", "OATP1B3", "OCT2"], "gold": [], "text": "[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA)."}, {"generated": ["concomitant herbal use"], "gold": [], "text": "showed that the practice of herbal co-medication with prescription drugs cut across various patient demographics, with 38% of respondents reporting concomitant herbal use [6]."}, {"generated": ["kava"], "gold": [], "text": "Despite the general concern about its safety, kava is still popularly consumed for CNS benefits."}, {"generated": ["SJW"], "gold": [], "text": "Apart from CYP/P-gp induction, SJW mediates interactions through its serotonergic effects."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "This is important because the vast majority of herbal products are orally administered."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "This is because many marketed herbal products are made of mixtures of different herbal species and/or dietary supplements whose biological disposition in humans is poorly understood."}, {"generated": ["echinacea", "piperine", "celery", "rhodiola", "moringa", "terminalia/commiphora ayurvedic mixture", "ginkgo", "ginseng"], "gold": ["hydroxycut"], "text": "This review identified 13 herbal products - celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John\u2019s wort, terminalia/commiphora ayurvedic mixture and valerian \u2013 all of which have shown interactions with specific neuropsychiatric drugs."}, {"generated": ["echinacea", "piperine", "celery", "rhodiola", "moringa", "terminalia/commiphora ayurvedic mixture", "ginkgo", "ginseng"], "gold": ["hydroxycut"], "text": "This review identified 13 herbal products - celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John\u2019s wort, terminalia/commiphora ayurvedic mixture and valerian \u2013 all of which have shown interactions with specific neuropsychiatric drugs."}, {"generated": ["echinacea", "piperine", "celery", "rhodiola", "moringa", "terminalia/commiphora ayurvedic mixture", "ginkgo", "ginseng"], "gold": ["hydroxycut"], "text": "This review identified 13 herbal products - celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John\u2019s wort, terminalia/commiphora ayurvedic mixture and valerian \u2013 all of which have shown interactions with specific neuropsychiatric drugs."}, {"generated": ["echinacea", "piperine", "celery", "rhodiola", "moringa", "terminalia/commiphora ayurvedic mixture", "ginkgo", "ginseng"], "gold": ["hydroxycut"], "text": "This review identified 13 herbal products - celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John\u2019s wort, terminalia/commiphora ayurvedic mixture and valerian \u2013 all of which have shown interactions with specific neuropsychiatric drugs."}, {"generated": ["echinacea", "piperine", "celery", "rhodiola", "moringa", "terminalia/commiphora ayurvedic mixture", "ginkgo", "ginseng"], "gold": ["hydroxycut"], "text": "This review identified 13 herbal products - celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John\u2019s wort, terminalia/commiphora ayurvedic mixture and valerian \u2013 all of which have shown interactions with specific neuropsychiatric drugs."}, {"generated": ["echinacea", "piperine", "celery", "rhodiola", "moringa", "terminalia/commiphora ayurvedic mixture", "ginkgo", "ginseng"], "gold": ["hydroxycut"], "text": "This review identified 13 herbal products - celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John\u2019s wort, terminalia/commiphora ayurvedic mixture and valerian \u2013 all of which have shown interactions with specific neuropsychiatric drugs."}, {"generated": ["echinacea", "piperine", "celery", "rhodiola", "moringa", "terminalia/commiphora ayurvedic mixture", "ginkgo", "ginseng"], "gold": ["hydroxycut"], "text": "This review identified 13 herbal products - celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John\u2019s wort, terminalia/commiphora ayurvedic mixture and valerian \u2013 all of which have shown interactions with specific neuropsychiatric drugs."}, {"generated": ["echinacea", "piperine", "celery", "rhodiola", "moringa", "terminalia/commiphora ayurvedic mixture", "ginkgo", "ginseng"], "gold": ["hydroxycut"], "text": "This review identified 13 herbal products - celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John\u2019s wort, terminalia/commiphora ayurvedic mixture and valerian \u2013 all of which have shown interactions with specific neuropsychiatric drugs."}, {"generated": ["Medicinal herbs"], "gold": [], "text": "Medicinal herbs are rich sources of natural bioactive compounds that could interact with drugs."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Author contributions: MK drafted the initial and final versions of the manuscript."}, {"generated": ["Parsley"], "gold": [], "text": "Parsley, Petroselinum crispum, is a food, spice, and also a medicinal herb."}, {"generated": ["Parsley"], "gold": [], "text": "Parsley is a food, spice, and also a medicinal herb."}, {"generated": ["parsley"], "gold": [], "text": "In this patient, we reported the possible effect of parsley juice on the level of sirolimus."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Data are expressed as mean \u00b1 S. D. (n = 6)."}, {"generated": ["Epimedium sagittatum extract"], "gold": [], "text": "The AUC data showed statistically significant differences between group 1 and 2 and between groups 2 and 3 possibly suggest the herb-drug interaction between Epimedium sagittatum extract and sildenafil."}, {"generated": ["root", "stem", "rhizome", "leaves"], "gold": [], "text": "et Zucc.)"}, {"generated": ["root", "stem", "rhizome", "leaves"], "gold": [], "text": "et Zucc.)"}, {"generated": ["root", "stem", "rhizome", "leaves"], "gold": [], "text": "et Zucc.)"}, {"generated": ["root", "stem", "rhizome", "leaves"], "gold": [], "text": "et Zucc.)"}, {"generated": ["Epimedium sagittatum"], "gold": [], "text": "Second, the pretreatment period of Epimedium sagittatum extract might have been too short to identify the possible herbal drug effect."}, {"generated": ["combined extraction"], "gold": [], "text": "The combined extraction solution was then evaporated to dryness."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Maxim extract are available from the authors."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "It most often means that we have less knowledge of benefits, as well as risks."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "From the combined literature, a list of the most frequently occurring species was established."}, {"generated": ["plants"], "gold": [], "text": "Thus, two studies from Canada and the USA were screened to find plants that patients might use."}, {"generated": ["potentially hepatotoxic herbs"], "gold": [], "text": "Many potentially hepatotoxic herbs are not studied extensively enough to determine a safe daily dose."}, {"generated": ["leaf powder"], "gold": ["leaf"], "text": "Another patient experienced liver injury after taking 500 mg leaf powder every 2\u20133 days as a laxative [117]."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "There are only food supplements available, with insufficiently defined product quality."}, {"generated": ["Cannabis preparations"], "gold": [], "text": "Cannabis preparations are emerging as a promising option for co-treatment of inflammatory diseases."}, {"generated": ["parts of herb used"], "gold": [], "text": "This is debated, and there are hints to possible beneficial effects [135]."}, {"generated": ["refined quantified dry extract"], "gold": [], "text": "For the refined quantified dry extract, the ginkgolic acid content is limited to 5 ppm [154]."}, {"generated": ["root"], "gold": [], "text": "The term \u201cginseng\u201d can be used for several drugs."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Seong et al."}, {"generated": ["parts of herb"], "gold": [], "text": "A scientific opinion of EFSA [196] from 2018 states that the common food consumption is safe, as there are only few cases of HILI associated with tea consumption despite the widespread use."}, {"generated": ["green tea"], "gold": [], "text": "applied atorvastatin in rats after 3 weeks of drinking green tea or water."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "They favor CYP, as the patient could be unusually susceptible due to the individual genotype [207]."}, {"generated": ["plants"], "gold": [], "text": "It is important to make patients aware of the fact that plants can cause adverse effects and are not safe in every situation by being \u201cnatural\u201d."}, {"generated": ["Valerian"], "gold": [], "text": "Valerian, for example, is marketed in Germany, mainly as HMP, and, thus, possibly a great proportion of consumption was not included in the survey by Garcia-Alvarez [7]."}, {"generated": ["root", "leaf", "flower", "seed"], "gold": [], "text": "This may result in translation errors or assigning mentions to the wrong species, in some cases."}, {"generated": ["root", "leaf", "flower", "seed"], "gold": [], "text": "This may result in translation errors or assigning mentions to the wrong species, in some cases."}, {"generated": ["root", "leaf", "flower", "seed"], "gold": [], "text": "This may result in translation errors or assigning mentions to the wrong species, in some cases."}, {"generated": ["root", "leaf", "flower", "seed"], "gold": [], "text": "This may result in translation errors or assigning mentions to the wrong species, in some cases."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Publisher\u2019s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Herb\u2013drug interactions (HDI) may affect clinical safety and efficacy via additive/synergistic or antagonistic interactions among the herbal components and drug molecules."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "When these herbs and drugs are used together, pharmacodynamic HDI (either additive/synergistic) may occur."}, {"generated": ["allyl thiosulfinates", "Sulfur compounds", "allyl"], "gold": [], "text": "It is composed of a large number of sulfur compounds, with suspected bioactive compounds called allyl thiosulfinates (mainly allicin) [65]."}, {"generated": ["allyl thiosulfinates", "Sulfur compounds", "allyl"], "gold": [], "text": "It is composed of a large number of sulfur compounds, with suspected bioactive compounds called allyl thiosulfinates (mainly allicin) [65]."}, {"generated": ["allyl thiosulfinates", "Sulfur compounds", "allyl"], "gold": [], "text": "It is composed of a large number of sulfur compounds, with suspected bioactive compounds called allyl thiosulfinates (mainly allicin) [65]."}, {"generated": ["not specified"], "gold": [], "text": "This herb has been in use for diabetic treatment for almost two millennia [72]."}, {"generated": ["gymnema"], "gold": [], "text": "These findings suggest further research in individuals with diabetes is required to determine the effect of the combination of gymnema tea and metformin on blood sugar levels."}, {"generated": ["Lycium"], "gold": [], "text": "Evidence supporting the interaction between Lycium and antidiabetics is experimental only."}, {"generated": ["no interaction"], "gold": [], "text": "no interaction [98]."}, {"generated": ["Not applicable"], "gold": [], "text": "System-to-system or systems biology methodology is a more appropriate model for the evaluation of more complex interactions but its use is often limited by the availability of the relevant chemical and pharmacological data, especially in complex herbal interventions."}, {"generated": ["List of parts of herb used found in text"], "gold": [], "text": "Conversely, it is important to keep in mind that these interactions may also present therapeutic benefits as a result of synergism which may lead to enhanced drug effects or reduced adverse reactions."}, {"generated": ["DEX"], "gold": [], "text": "So, DEX has been used as a common probe for both CYP3A and CYP2D6 activities (Spanakis et al., 2009; Yu and Haining, 2001), as well as in vivo in several studies (Ducharme et al., 1996; Funck-Brentano et al., 2005; Jones et al., 1996)."}, {"generated": ["Asafetida resin"], "gold": [], "text": "In the in vitro study, Asafetida resin alcoholic extract inhibited the formation of DOR from DEX in a concentration dependent manner (Fig."}, {"generated": ["Asafetida"], "gold": [], "text": "In conclusion, the significant Asafetida inhibitory effect on CYP3A4 metabolic activity was an important finding of this study."}, {"generated": ["pieces of herb"], "gold": [], "text": "Moreover, the reckless pieces of information about possible effects of diet, such as fatigue and loose stools, elicited confusion in the patient."}], "FN": [{"generated": [], "gold": ["the roots"], "text": "The two major classes of compounds isolated from the roots of KF are alkyl phenols and triterpene glycosides (saponins) as reported earlier (Ali and Khan, 2011)."}, {"generated": [], "gold": ["roots", "aerial parts"], "text": "Our commercial product was only labelled to contain 95% aerial parts and 5% roots of E. purpurea, and no information was provided about the total amount of extract used."}, {"generated": [], "gold": ["roots", "aerial parts"], "text": "Our commercial product was only labelled to contain 95% aerial parts and 5% roots of E. purpurea, and no information was provided about the total amount of extract used."}, {"generated": [], "gold": ["roots", "leaves"], "text": "For example, alkylamide content is known to vary considerably across different parts of E. purpurea plants [20], and DTAI are more abundant in roots than in leaves."}, {"generated": [], "gold": ["roots", "leaves"], "text": "For example, alkylamide content is known to vary considerably across different parts of E. purpurea plants [20], and DTAI are more abundant in roots than in leaves."}, {"generated": [], "gold": ["seeds"], "text": "[4] Studies on phytochemical analysis of G. kola seeds [6\u201311] reveal benxophenones, xanthones, alkaloids, phenols, tannins and saponins, kolaviron a biflavonoid complex, and metallic ions such as aluminum, magnesium, calcium and copper as major chemical components of G. kola."}, {"generated": [], "gold": ["seeds"], "text": "Pregnancy, breastfeeding, histories of hypersensitivity to quinine or similar agents, or adverse side effects from taking G. kola seeds were also used as exclusion criteria for the study."}, {"generated": ["valerian root"], "gold": ["root"], "text": "Recommended daily doses of valerian root extracts are about 600\u2009mg, usually taken as capsules or tablets."}, {"generated": [], "gold": ["Radis", "cortex", "Radix", "Tuber", "Pollen", "Rhizoma"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": [], "gold": ["Radis", "cortex", "Radix", "Tuber", "Pollen", "Rhizoma"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": [], "gold": ["Radis", "cortex", "Radix", "Tuber", "Pollen", "Rhizoma"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": [], "gold": ["Radis", "cortex", "Radix", "Tuber", "Pollen", "Rhizoma"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": [], "gold": ["Radis", "cortex", "Radix", "Tuber", "Pollen", "Rhizoma"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": [], "gold": ["Radis", "cortex", "Radix", "Tuber", "Pollen", "Rhizoma"], "text": "Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol."}, {"generated": [], "gold": ["seed"], "text": "Dried seed of Eugenia jambolana were powdered and used for preparation of aqueous extract by using the double maceration technique."}, {"generated": ["deeper red calyxes"], "gold": ["calyxes"], "text": "The HS varieties with deeper red calyxes exhibited greater antioxidant activity as compared to lighter red or white varieties [44, 45]."}, {"generated": ["Allium sativum bulbs"], "gold": ["bulbs"], "text": "In this study, aqueous extract of oven\u2010dried Allium sativum bulbs was used."}, {"generated": ["Moringa oleifera leaves"], "gold": ["leaves"], "text": "Aqueous extract of Moringa oleifera leaves showed weak inhibition of CYP1A2 and CYP2C9."}, {"generated": ["Root of Isatis indigotica"], "gold": ["Root"], "text": "Radix Isatidis (Root of Isatis indigotica Fort., Banlangen)."}, {"generated": ["Fruit of Arctium lappa L., Niubangzi"], "gold": ["Fruit"], "text": "Fructus Arctii (Fruit of Arctium lappa L., Niubangzi)."}, {"generated": ["echinacea", "piperine", "celery", "rhodiola", "moringa", "terminalia/commiphora ayurvedic mixture", "ginkgo", "ginseng"], "gold": ["hydroxycut"], "text": "This review identified 13 herbal products - celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John\u2019s wort, terminalia/commiphora ayurvedic mixture and valerian \u2013 all of which have shown interactions with specific neuropsychiatric drugs."}, {"generated": ["leaf powder"], "gold": ["leaf"], "text": "Another patient experienced liver injury after taking 500 mg leaf powder every 2\u20133 days as a laxative [117]."}]}